IL1B and neoplasm: Although IL-1β was not a strong stimulant of EMT, it is possible that this cytokine supports tumor recurrence or metastasis by other means, such as increased angiogenesis, as indicated by several published studies [28,31,83], or by having joint activity with other factors.